Reply to Letter to the Editor Regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five Year Real World Outcomes” by Meulmeester et al.
International Forum of Allergy & Rhinology · 2026-11 · 16 (11) · 1389-1391
DOI: 10.1002/alr.70293 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 18.10.2026. Verfasst von Nicholas J Campion und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Vienna Airway Lab, General Hospital and Medical University of Vienna, Vienna, Austria. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Vienna Airway Lab, General Hospital and Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Nicholas J Campion, Minghao Pan, Julia Eckl-Dorna
Zitieren
APA
Campion, N. J., Petsiou, D. P., Fally, F. C., Berbalk, K., Melamed, N. F., Tu, A., Morgenstern, C., Kidane, F. A., Zghaebi, M., Liu, L., Pan, M., Bartosik, T. J., Stanek, V., Gangl, K., Eckl-Dorna, J., & Schneider, S. (2026). Reply to Letter to the Editor Regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five Year Real World Outcomes” by Meulmeester et al. International Forum of Allergy & Rhinology, 16(11), 1389-1391. https://doi.org/10.1002/alr.70293
Vancouver
Campion NJ, Petsiou DP, Fally FC, Berbalk K, Melamed NF, Tu A, et al. Reply to Letter to the Editor Regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five Year Real World Outcomes” by Meulmeester et al. International Forum of Allergy & Rhinology. 2026;16(11):1389-1391. doi:10.1002/alr.70293
BibTeX
@article{Campion2026,
author = {Campion, Nicholas J and Petsiou, Dioni-Pinelopi and Fally, Florian C and Berbalk, Karina and Melamed, Noah F and Tu, Aldine and Morgenstern, Christina and Kidane, Fana Alem and Zghaebi, Mohammed and Liu, Linda and Pan, Minghao and Bartosik, Tina J and Stanek, Victoria and Gangl, Katarina and Eckl-Dorna, Julia and Schneider, Sven},
title = {Reply to Letter to the Editor Regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five Year Real World Outcomes” by Meulmeester et al},
journal = {International Forum of Allergy & Rhinology},
year = {2026},
volume = {16},
number = {11},
pages = {1389--1391},
doi = {10.1002/alr.70293}
}
EUVIMED